147 related articles for article (PubMed ID: 9285207)
1. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus.
Zumbach M; Hofmann M; Borcea V; Luther T; Kotzsch M; Müller M; Hergesell O; Andrassy K; Ritz E; Ziegler R; Wahl P; Nawroth PP
Exp Clin Endocrinol Diabetes; 1997; 105(4):206-12. PubMed ID: 9285207
[TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
3. [Modification of hemorheological parameters in microvascular complications of diabetes].
Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
[TBL] [Abstract][Full Text] [Related]
5. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications.
Buchs AE; Kornberg A; Zahavi M; Aharoni D; Zarfati C; Rapoport MJ
Exp Diabesity Res; 2004; 5(2):163-9. PubMed ID: 15203887
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
[TBL] [Abstract][Full Text] [Related]
8. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
[TBL] [Abstract][Full Text] [Related]
9. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
[TBL] [Abstract][Full Text] [Related]
11. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
Seghieri G; Bartolomei G; De Giorgio LA
Diabete Metab; 1986 Aug; 12(4):186-90. PubMed ID: 3770274
[TBL] [Abstract][Full Text] [Related]
14. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
15. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of various hemorheologic parameters in diabetes mellitus].
Cella A; Bianchi E; Reali GL; Piana A; Armani U
Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelin-1 in non-insulin-dependent diabetic patients with retinopathy.
Letizia C; Iannaccone A; Cerci S; Santi G; Cilli M; Coassin S; Pannarale MR; Scavo D
Horm Metab Res; 1997 May; 29(5):247-51. PubMed ID: 9228211
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage.
Laurenti O; Vingolo EM; Desideri GB; Ferri C; Bellini C; Cassone-Faldetta M; Santucci A; De Mattia G
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():40-2. PubMed ID: 9288543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
